COTY INC. 10-Q Summary: Fiscal Q2 2026 (Ended Dec 31, 2025)
Business Context and Reporting Period
This report covers the three and six months ended December 31, 2025 (Fiscal Q2 2026). Coty Inc. is a global beauty company manufacturing and distributing fragrances, color cosmetics, and skin & body care products. The period was marked by significant strategic changes, including the sale of the company's remaining equity interest in Wella, leadership transitions with Markus Strobel appointed as Interim CEO effective January 1, 2026, and ongoing cost reduction initiatives.
Key Financial Metrics
| Metric (in millions) | 3 Months Ended Dec 31, 2025 | 6 Months Ended Dec 31, 2025 |
|---|---|---|
| Net Revenues | $1,678.6 | $3,255.8 |
| Gross Profit | $1,070.6 | $2,087.4 |
| Operating Income | $148.2 | $333.2 |
| Net (Loss) Income Attributable to Coty Inc. | $(123.6) | $(55.7) |
| Diluted EPS (Basic) | $(0.14) | $(0.07) |
| Operating Cash Flow (6mo) | $624.9 | |
| Total Debt (Long-term + Current) | $3,038.1 | |
| Cash and Cash Equivalents | $436.7 |
Material Changes vs. Prior Period
- Revenue: Net revenues increased 1% ($8.7M) in Q2 compared to the prior year, driven by a 4% positive foreign currency impact and 1% volume growth, offset by a 4% negative price/mix impact. For the six-month period, revenues decreased 3% ($85.6M) due to volume declines in color cosmetics and mass fragrance.
- Profitability: Operating income decreased 45% to $148.2M in Q2, primarily due to higher cost of sales (tariffs, material costs), increased amortization, and an early license termination cost of $19.7M. Operating margin compressed to 8.8% from 16.1% in the prior year.
- Net Loss: The company reported a net loss of $123.6M in Q2, a reversal from a $23.7M profit in the prior year. This was significantly impacted by a $201.9M realized loss on the sale of the Wella equity investment.
- Segment Performance: The Prestige segment operating income declined 18% to $181.9M, while Consumer Beauty operating income dropped 71% to $18.3M, pressured by lower-margin sales in Brazil and U.S. color cosmetics weakness.
Guidance, Outlook, and Risks
- Outlook: Management expects Q3 fiscal 2026 net revenue to decline compared to the prior year, with a low to mid-single-digit benefit from foreign exchange. Gross margins are expected to be pressured by lower sales and tariff impacts.
- Cost Reduction: The company is re-accelerating cost reduction efforts, targeting approximately $80.0M in savings for fiscal 2026.
- Tariff Impact: Estimated operating results impact from tariff increases is approximately $33.0M through Q1 fiscal 2027, with $28.0M expected in fiscal 2026.
- Debt Management: The company continues to deleverage. Proceeds from the Wella sale ($750M) and a new $900M bond issuance were used to redeem approximately $1.4B in senior secured notes, reducing total debt significantly.
- Risks: Key risks include ongoing talc-related litigation, Brazilian tax assessments (requiring significant surety bonds), geopolitical conflicts affecting supply chains, and the impact of tariffs on prestige fragrances.
Investor Verification Checklist
- Wella Sale Impact: Verify the long-term implications of the $201.9M loss on the Wella sale and the future value of the retained "Wella Distribution Rights" ($58.0M fair value).
- Tariff Mitigation: Assess the effectiveness of supply chain diversification and pricing strategies to offset the estimated $33.0M tariff cost.
- Consumer Beauty Turnaround: Monitor the execution of the performance improvement plan for the Consumer Beauty segment, specifically regarding U.S. color cosmetics market share.
- Debt Covenant Compliance: Confirm continued compliance with the Total Net Leverage Ratio covenant (4.00:1.00) given the recent debt refinancing and redemption activities.
- Legal Contingencies: Review the status of Brazilian tax assessments and talc litigation, noting the requirement for substantial surety bonds and cash deposits.